- Home
- EUDA vs SGHT Comparison
EUDA vs SGHT Comparison
Compare EUDA & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EUDA
- SGHT
- Stock Information
- Founded
- EUDA 2021
- SGHT 2011
- Country
- EUDA Singapore
- SGHT United States
- Employees
- EUDA N/A
- SGHT N/A
- Industry
- EUDA Blank Checks
- SGHT Medical Specialities
- Sector
- EUDA Finance
- SGHT Health Care
- Exchange
- EUDA Nasdaq
- SGHT Nasdaq
- Market Cap
- EUDA 146.0M
- SGHT 222.3M
- IPO Year
- EUDA N/A
- SGHT 2021
- Fundamental
- Price
- EUDA $3.30
- SGHT $3.50
- Analyst Decision
- EUDA
- SGHT Buy
- Analyst Count
- EUDA 0
- SGHT 8
- Target Price
- EUDA N/A
- SGHT $4.01
- AVG Volume (30 Days)
- EUDA 93.4K
- SGHT 172.5K
- Earning Date
- EUDA 01-01-0001
- SGHT 07-31-2025
- Dividend Yield
- EUDA N/A
- SGHT N/A
- EPS Growth
- EUDA N/A
- SGHT N/A
- EPS
- EUDA N/A
- SGHT N/A
- Revenue
- EUDA $4,011,005.00
- SGHT $78,109,000.00
- Revenue This Year
- EUDA $212.19
- SGHT N/A
- Revenue Next Year
- EUDA $254.35
- SGHT $11.60
- P/E Ratio
- EUDA N/A
- SGHT N/A
- Revenue Growth
- EUDA 8.22
- SGHT N/A
- 52 Week Low
- EUDA $2.92
- SGHT $2.03
- 52 Week High
- EUDA $6.30
- SGHT $8.45
- Technical
- Relative Strength Index (RSI)
- EUDA 41.59
- SGHT 38.82
- Support Level
- EUDA $3.35
- SGHT $3.36
- Resistance Level
- EUDA $3.60
- SGHT $4.33
- Average True Range (ATR)
- EUDA 0.15
- SGHT 0.27
- MACD
- EUDA -0.02
- SGHT -0.12
- Stochastic Oscillator
- EUDA 0.00
- SGHT 13.07
About EUDA EUDA Health Holdings Limited
EUDA Health Holdings Ltd is a non-invasive healthcare company across Southeast Asia and China. The Company has two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include common area property management services that contain cleaning, landscaping, public facilities maintenance and other traditional services and also include security property management services provided to all tenants and property owners.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.